Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Carlson

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Biotechnology Healthcare|February 9, 2013
Diagnostic assays a key to personalized medicineBob Carlson
Biotechnology Healthcare|February 2, 2013
2003 was stellar for biotechs; new applications make 2004 promisingBob Carlson
Biotechnology Healthcare|February 2, 2013
McClellan's Legacy: Activism, PartnershipBob Carlson
Biotechnology Healthcare|January 16, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|January 16, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|October 24, 2012
iSPOT-D Trial Has Potential To Personalize Antidepressant TreatmentBob Carlson
Biotechnology Healthcare|August 10, 2012
Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
HCV testing cost-effective alternative to treating advanced diseaseBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Biotechnology Healthcare|February 9, 2013
Diagnostic assays a key to personalized medicineBob Carlson
Biotechnology Healthcare|February 2, 2013
2003 was stellar for biotechs; new applications make 2004 promisingBob Carlson
Biotechnology Healthcare|February 2, 2013
McClellan's Legacy: Activism, PartnershipBob Carlson
Biotechnology Healthcare|January 16, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|January 16, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|October 24, 2012
iSPOT-D Trial Has Potential To Personalize Antidepressant TreatmentBob Carlson
Biotechnology Healthcare|August 10, 2012
Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Biotechnology Healthcare|February 21, 2013
HCV testing cost-effective alternative to treating advanced diseaseBob Carlson
Biotechnology Healthcare|February 21, 2013
Approvals, FDA actions, clinical trialsBob Carlson
Pageof 10